Evidence in support of this from individuals with CG shows that pathological accumulation of gal-1-P directly reduces both UDP-glc and UDP-gal bioavailability in GALT deficiency (Lai et al., 2003). The gene discussed is GAL; the disease is hyperinsulinemic hypoglycemia, familial, 4.